Literature DB >> 31495448

Heroin Cue-Evoked Astrocytic Structural Plasticity at Nucleus Accumbens Synapses Inhibits Heroin Seeking.

Anna Kruyer1, Michael D Scofield2, Daniel Wood3, Kathryn J Reissner4, Peter W Kalivas5.   

Abstract

BACKGROUND: Opioid addiction is a critical medical and societal problem characterized by vulnerability to relapse. Glutamatergic synapses in the nucleus accumbens regulate the motivation to relapse to opioid use, and downregulation of glutamate transporters on astroglial processes adjacent to accumbens synapses contributes to heroin seeking induced by cues. However, it is not known how astroglial processes themselves respond to heroin cues or if changes in astroglial morphology are necessary for heroin seeking.
METHODS: Male Sprague Dawley rats (n = 62) were trained to self-administer heroin or sucrose and were reinstated by heroin-conditioned or sucrose-conditioned cues. Astroglial proximity to accumbens synapses was estimated using a confocal-based strategy, and the association between digitally isolated astroglia and the presynaptic marker synapsin I was quantified. To determine the functional consequence of astroglial morphological plasticity on cued heroin seeking, a morpholino antisense strategy was used to knock down expression of the actin binding protein ezrin, which is expressed almost exclusively in peripheral astroglial processes in the adult rat brain.
RESULTS: After heroin extinction, there was an enduring reduction in synaptic proximity by astroglia. Synaptic proximity was restored during 15 minutes of cued heroin seeking but returned to extinction levels by 120 minutes. Extinction from sucrose self-administration and reinstated sucrose seeking induced no changes in astroglial synaptic association. Ezrin knockdown reduced astroglial association with synapses and potentiated cued heroin seeking.
CONCLUSIONS: Cue-induced heroin seeking transiently increased synaptic proximity of accumbens astrocytes. Surprisingly, the reassociation of astroglia with synapses was compensatory, and preventing cue-induced morphological plasticity in astrocytes potentiated heroin seeking.
Copyright © 2019 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Addiction; Astrocyte; Heroin; Nucleus accumbens; Self-administration; Synapse

Mesh:

Substances:

Year:  2019        PMID: 31495448      PMCID: PMC6823145          DOI: 10.1016/j.biopsych.2019.06.026

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  44 in total

1.  Asymmetry of glia near central synapses favors presynaptically directed glutamate escape.

Authors:  Knut Petter Lehre; Dmitri A Rusakov
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

2.  Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry.

Authors:  F A Chaudhry; K P Lehre; M van Lookeren Campagne; O P Ottersen; N C Danbolt; J Storm-Mathisen
Journal:  Neuron       Date:  1995-09       Impact factor: 17.173

3.  An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex.

Authors:  Ye Zhang; Kenian Chen; Steven A Sloan; Mariko L Bennett; Anja R Scholze; Sean O'Keeffe; Hemali P Phatnani; Paolo Guarnieri; Christine Caneda; Nadine Ruderisch; Shuyun Deng; Shane A Liddelow; Chaolin Zhang; Richard Daneman; Tom Maniatis; Ben A Barres; Jian Qian Wu
Journal:  J Neurosci       Date:  2014-09-03       Impact factor: 6.167

4.  Synaptic glutamate spillover due to impaired glutamate uptake mediates heroin relapse.

Authors:  Hao-wei Shen; Michael D Scofield; Heather Boger; Megan Hensley; Peter W Kalivas
Journal:  J Neurosci       Date:  2014-04-16       Impact factor: 6.167

5.  Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.

Authors:  K D Geiger; P Stoldt; W Schlote; A Derouiche
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

Review 6.  Reappraising striatal D1- and D2-neurons in reward and aversion.

Authors:  Carina Soares-Cunha; Barbara Coimbra; Nuno Sousa; Ana J Rodrigues
Journal:  Neurosci Biobehav Rev       Date:  2016-05-24       Impact factor: 8.989

Review 7.  Diversity of astrocyte functions and phenotypes in neural circuits.

Authors:  Baljit S Khakh; Michael V Sofroniew
Journal:  Nat Neurosci       Date:  2015-07       Impact factor: 24.884

8.  Gq-DREADD Selectively Initiates Glial Glutamate Release and Inhibits Cue-induced Cocaine Seeking.

Authors:  Michael D Scofield; Heather A Boger; Rachel J Smith; Hao Li; Philip G Haydon; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2015-02-24       Impact factor: 13.382

9.  Identification of synapsin I peptides that insert into lipid membranes.

Authors:  J J Cheetham; S Hilfiker; F Benfenati; T Weber; P Greengard; A J Czernik
Journal:  Biochem J       Date:  2001-02-15       Impact factor: 3.857

Review 10.  The Gliocentric Brain.

Authors:  James M Robertson
Journal:  Int J Mol Sci       Date:  2018-10-05       Impact factor: 5.923

View more
  28 in total

Review 1.  Astrocyte regulation of synaptic signaling in psychiatric disorders.

Authors:  Anna Kruyer; Peter W Kalivas; Michael D Scofield
Journal:  Neuropsychopharmacology       Date:  2022-05-16       Impact factor: 7.853

2.  Prefrontal fNIRS-based clinical data analysis of brain functions in individuals abusing different types of drugs.

Authors:  Xuelin Gu; Banghua Yang; Shouwei Gao; Lin Feng Yan; Ding Xu; Wen Wang
Journal:  J Biomed Semantics       Date:  2021-11-25

Review 3.  Extrasynaptic therapeutic targets in substance use and stress disorders.

Authors:  Ritchy Hodebourg; Peter W Kalivas; Anna Kruyer
Journal:  Trends Pharmacol Sci       Date:  2021-11-06       Impact factor: 14.819

Review 4.  A novel approach to treating opioid use disorders: Dual agonists of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors.

Authors:  Riley Merkel; Amanda Moreno; Yafang Zhang; Rachel Herman; Jennifer Ben Nathan; Sana Zeb; Suditi Rahematpura; Kamryn Stecyk; Brandon T Milliken; Matthew R Hayes; Robert P Doyle; Heath D Schmidt
Journal:  Neurosci Biobehav Rev       Date:  2021-10-29       Impact factor: 8.989

5.  High-Resolution Three-Dimensional Imaging of Individual Astrocytes Using Confocal Microscopy.

Authors:  Anze Testen; Ronald Kim; Kathryn J Reissner
Journal:  Curr Protoc Neurosci       Date:  2020-03

6.  In vivo reduction of striatal D1R by RNA interference alters expression of D1R signaling-related proteins and enhances methamphetamine addiction in male rats.

Authors:  Alison D Kreisler; Michael J Terranova; Sucharita S Somkuwar; Dvijen C Purohit; Shanshan Wang; Brian P Head; Chitra D Mandyam
Journal:  Brain Struct Funct       Date:  2020-04-03       Impact factor: 3.270

7.  Relapse-Associated Transient Synaptic Potentiation Requires Integrin-Mediated Activation of Focal Adhesion Kinase and Cofilin in D1-Expressing Neurons.

Authors:  Constanza Garcia-Keller; Michael D Scofield; Daniela Neuhofer; Swathi Varanasi; Matthew T Reeves; Brandon Hughes; Ethan Anderson; Christopher T Richie; Carlos Mejias-Aponte; James Pickel; Bruce T Hope; Brandon K Harvey; Christopher W Cowan; Peter W Kalivas
Journal:  J Neurosci       Date:  2020-10-13       Impact factor: 6.167

Review 8.  Astrocytes as cellular mediators of cue reactivity in addiction.

Authors:  Anna Kruyer; Peter W Kalivas
Journal:  Curr Opin Pharmacol       Date:  2020-08-27       Impact factor: 5.547

Review 9.  Glutamatergic Systems and Memory Mechanisms Underlying Opioid Addiction.

Authors:  Jasper A Heinsbroek; Taco J De Vries; Jamie Peters
Journal:  Cold Spring Harb Perspect Med       Date:  2021-03-01       Impact factor: 6.915

10.  Heroin Seeking and Extinction From Seeking Activate Matrix Metalloproteinases at Synapses on Distinct Subpopulations of Accumbens Cells.

Authors:  Vivian C Chioma; Anna Kruyer; Ana-Clara Bobadilla; Ariana Angelis; Zachary Ellison; Ritchy Hodebourg; Michael D Scofield; Peter W Kalivas
Journal:  Biol Psychiatry       Date:  2020-12-09       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.